These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34668889)

  • 81. CRISPR/Cas9 system and its applications in human hematopoietic cells.
    Hu X
    Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Human fetal mesenchymal stem cells.
    O'Donoghue K; Chan J
    Curr Stem Cell Res Ther; 2006 Sep; 1(3):371-86. PubMed ID: 18220881
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.
    Witt RG; Kreger EM; Buckman LB; Moradi PW; Ho PT; Derderian SC; Tsai P; Baker C; Schramm N; Cleary R; Garcia JV; MacKenzie TC
    Blood Adv; 2018 Jan; 2(1):69-74. PubMed ID: 29344586
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells.
    Carrier E; Lee TH; Busch MP; Cowan MJ
    Blood; 1995 Dec; 86(12):4681-90. PubMed ID: 8541562
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Current State and Future of Fetal Therapies.
    Sparks TN
    Clin Obstet Gynecol; 2021 Dec; 64(4):926-932. PubMed ID: 34560766
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Prenatal stem cell transplantation: from bench to bedside].
    Surbek DV; Holzgreve W
    Ther Umsch; 2002 Nov; 59(11):619-23. PubMed ID: 12498056
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Rescue of neonatal cardiac dysfunction in mice by administration of cardiac progenitor cells in utero.
    Liu X; Hall SRR; Wang Z; Huang H; Ghanta S; Di Sante M; Leri A; Anversa P; Perrella MA
    Nat Commun; 2015 Nov; 6():8825. PubMed ID: 26593099
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Fetal therapy of skeletal dysplasias].
    Murotsuki J
    Clin Calcium; 2013 Dec; 23(12):1784-8. PubMed ID: 24292533
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In utero stem cell transplantation: a European overview.
    Jones DR
    Fetal Diagn Ther; 2004; 19(3):207-11. PubMed ID: 15067228
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fetal hematopoietic stem cell transplantation.
    Shaaban AF; Flake AW
    Semin Perinatol; 1999 Dec; 23(6):515-23. PubMed ID: 10630547
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In utero haematopoietic stem cell transplantation. Experiences in mice, sheep and humans.
    Troeger C; Surbek D; Schöberlein A; Schatt S; Dudler L; Hahn S; Holzgreve W
    Swiss Med Wkly; 2006 Aug; 136(31-32):498-503. PubMed ID: 16947088
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evidence for an immune barrier after in utero hematopoietic-cell transplantation.
    Peranteau WH; Endo M; Adibe OO; Flake AW
    Blood; 2007 Feb; 109(3):1331-3. PubMed ID: 17023584
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Intrauterine transplantation of hematopoietic stem cells for therapy of genetic diseases].
    Surbek DV; Hohlfeld P; Gratwohl A; Holzgreve W
    Z Geburtshilfe Neonatol; 1997; 201(5):158-70. PubMed ID: 9440955
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
    Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
    Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
    Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
    Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In utero gene therapy is still a distant promise.
    Jenks S
    J Natl Cancer Inst; 1999 May; 91(10):829-30. PubMed ID: 10340901
    [No Abstract]   [Full Text] [Related]  

  • 97. Innovations in CRISPR-Based Therapies.
    Kesavan G
    Mol Biotechnol; 2023 Feb; 65(2):138-145. PubMed ID: 34586618
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
    Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
    Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prenatal Gene Therapy.
    Schwab ME; MacKenzie TC
    Clin Obstet Gynecol; 2021 Dec; 64(4):876-885. PubMed ID: 34618719
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Fetal gene therapy.
    Waddington SN; Peranteau WH; Rahim AA; Boyle AK; Kurian MA; Gissen P; Chan JKY; David AL
    J Inherit Metab Dis; 2024 Jan; 47(1):192-210. PubMed ID: 37470194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.